Abrishami Mojtaba, Daneshvar Ramin, Emamverdian Zahra, Saeedian Neda, Tohidinezhad Fariba, Eslami Saeid, Ansari-Astaneh Mohammad-Reza
Eye Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
J Ophthalmic Inflamm Infect. 2022 Jun 18;12(1):18. doi: 10.1186/s12348-022-00297-z.
This study aimed to evaluate the retinal and choroidal changes in the macular region of patients with Coronavirus Disease 2019 (COVID-19) using structural spectral-domain optical coherence tomography (SD-OCT) analysis.
This cross-sectional observational case-control study included patients recovered from COVID-19. The COVID-19 in all participants was confirmed using the reverse transcription-polymerase chain reaction (RT-PCR) technique. The participants had mild to moderate degree of disease without a history of hospitalization, steroid usage, or blood saturation below 92%. Macular SD-OCT was performed at least two weeks and up to one month after recovery from systemic COVID-19. Quantitative and qualitative changes detected by macular SD-OCT imaging were evaluated in COVID-19 recovered patients and compared with the results of age-matched normal controls.
Participants in this study included 30 cases (60 eyes) and 60 healthy controls (120 eyes). In total, 17 (28.3%) eyes in patient group showed at least one abnormal finding indicated by macular SD-OCT imaging included hyperreflective lesions in different retinal layers. In addition, dilated choroidal vessels and retinal pigment epitheliopathy were evident in 41 (68.3.6%) and 4 (6.6%) eyes in patient group, respectively, and their OCT findings resembled those with pachychoroid spectrum. No statistically significant differences were observed in retinal layers or retinal volume between the two groups. The mean ± SD subfoveal choroidal thickness (SFCT) was determined at 380.3 ± 12.40 μm, which was significantly thicker than that in control group (310.7 ± 57.5 μm) (P < 0.001).
Regarding retinal thickness, no significant change was observed in different retina layers of patients with COVID-19; however, there were striking qualitative changes, such as hyperreflective lesions in different retinal layers. The evaluation of choroidal structure and thickness demonstrated remarkable abnormal pachyvessels and significant thickening of the SFCT but the clinical significance of these findings is unknown.
本研究旨在通过结构光谱域光学相干断层扫描(SD-OCT)分析评估2019冠状病毒病(COVID-19)患者黄斑区的视网膜和脉络膜变化。
这项横断面观察性病例对照研究纳入了从COVID-19中康复的患者。所有参与者的COVID-19均采用逆转录聚合酶链反应(RT-PCR)技术确诊。参与者患有轻度至中度疾病,无住院史、未使用过类固醇,且血氧饱和度不低于92%。在从全身性COVID-19康复后至少两周至一个月进行黄斑SD-OCT检查。对COVID-19康复患者黄斑SD-OCT成像检测到的定量和定性变化进行评估,并与年龄匹配的正常对照组结果进行比较。
本研究的参与者包括30例(60只眼)和60名健康对照者(120只眼)。患者组共有17只眼(28.3%)表现出至少一项黄斑SD-OCT成像显示的异常发现,包括不同视网膜层的高反射性病变。此外,患者组分别有41只眼(68.3%)和4只眼(6.6%)出现脉络膜血管扩张和视网膜色素上皮病变,其OCT表现类似于厚脉络膜谱系。两组之间在视网膜层或视网膜体积方面未观察到统计学显著差异。平均±标准差中心凹下脉络膜厚度(SFCT)为380.3±12.40μm,显著厚于对照组(310.7±57.5μm)(P<0.001)。
关于视网膜厚度,COVID-19患者不同视网膜层未观察到显著变化;然而,存在明显的定性变化,如不同视网膜层的高反射性病变。脉络膜结构和厚度评估显示厚血管有显著异常,SFCT显著增厚,但这些发现的临床意义尚不清楚。